J&J says booster dose increased antibodies in early-stage studies
The Peninsula
CHICAGO: A booster dose of Johnson & Johnson's COVID-19 vaccine sharply increased levels of antibodies, according to interim data from two early-stage trials, the company said on Wednesday.
A second dose of the J&J single-dose vaccine resulted in binding antibody levels nine times higher than the levels 28 days after people received their first dose, the company said in a press release. Unlike neutralizing antibodies, which destroy the virus, binding antibodies attach to the virus but do not destroy it or prevent infection. Instead, they alert the immune system of its presence so white blood cells can be sent to destroy it.
Seoul: Samsung launched its first triple folding phone on Tuesday, a special edition product with an eyewatering price tag placing it out of the reach...
Doha, Qatar: The Safari 10, 20, 30 Promotion has started from December 1 at Safari, one of Doha s leading hypermarket chains. This is one of Safari...
DOHA: Pakistan International School Qatar (PISQ) commemorated Iqbal Day with great passion, respect, and national pride across all its wings, paying t...
Islamic Cultural Center holds lecture on youth empowerment in Islam at Mesaieed International School
Doha, Qatar: With the attendance of 210 students, the Sheikh Abdulla Bin Zaid Al Mahmoud Islamic Cultural Center organised a lecture entitled Youth E...
Doha, Qatar: The Ministry of Public Health (MoPH) has carried out an extensive inspection campaign that included a number of restaurants, cafes, and l...
Washington, USA: Amazon and Google announced the launch of a multi cloud networking service, jointly developed to meet the growing demand for reliable...
Doha, Qatar: Twenty students from the Community College visited the Sheikh Abdulla Bin Zaid Al Mahmoud Islamic Cultural Center, where they learned abo...
London, UK: The Winter egg, one of Faberge s most dazzling creations, is due to be auctioned in London next week and set another sales price record fo...